These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 34330230)
1. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases. Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230 [TBL] [Abstract][Full Text] [Related]
2. Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis. Zhou J; Zhang P; Tan Z; Li C; Yao L; Han Z; Yin Y BMC Infect Dis; 2024 Sep; 24(1):957. PubMed ID: 39261777 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789 [No Abstract] [Full Text] [Related]
4. Mother-to-child transmission of hepatitis B virus after amniocentesis: A retrospective matched cohort study. Han Z; Zhang Y; Bai X; Yin Y; Xu C; Hou H Prenat Diagn; 2019 May; 39(6):431-440. PubMed ID: 30916399 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Eke AC; Eleje GU; Eke UA; Xia Y; Liu J Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612 [TBL] [Abstract][Full Text] [Related]
6. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549 [TBL] [Abstract][Full Text] [Related]
7. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus. Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study. Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831 [TBL] [Abstract][Full Text] [Related]
9. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A; J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828 [TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction? Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis. Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930 [TBL] [Abstract][Full Text] [Related]
12. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China. Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437 [TBL] [Abstract][Full Text] [Related]
13. Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates. Peng TT; Cai QE; Yang M; Chen SP; Chen F; Wang M; Peng L; Wong G; Shen CG; Cheng WB; Liu SY; Peng YB; Peng JH; Chen CM; Yang LQ; Tang YM; Xu ZX; Liu YX Arch Virol; 2019 May; 164(5):1335-1341. PubMed ID: 30848390 [TBL] [Abstract][Full Text] [Related]
14. Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing. Su WJ; Chen HL; Chen SF; Liu YL; Wang TA; Ho YC; Chang MH Clin Infect Dis; 2024 Sep; 79(3):690-700. PubMed ID: 38562001 [TBL] [Abstract][Full Text] [Related]
15. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load? Aladag H; Aladag M Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508 [TBL] [Abstract][Full Text] [Related]
16. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China. Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789 [TBL] [Abstract][Full Text] [Related]
18. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing. Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580 [TBL] [Abstract][Full Text] [Related]
19. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia. E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167 [TBL] [Abstract][Full Text] [Related]
20. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission]. Yin YZ; Zhou J; Zhang PZ; Hou HY Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]